Search results
Showing 706 to 720 of 2185 results for guidelines
The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals.
using social care. It brings together our quality standards and medicines guidelines in an easy to use format, mapped against the Care...
Evidence based recommendations on patiromer (Veltassa) for treating hyperkalaemia in adults.
This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.
Good practice guidance – Integrated process statement (PMG12)
This process statement has been produced to explain how good practice guidance is developed. It provides an overview of the key process principles and describes all stages of the development of good practice guidance
NICE wants as many people as possible to be able to use our services, and we have designed it to be accessible.
Dapagliflozin in combination therapy for treating type 2 diabetes (TA288)
Evidence-based recommendations on dapagliflozin (Forxiga) given with other drugs for treating type 2 diabetes in adults.
Mirabegron for treating symptoms of overactive bladder (TA290)
Evidence-based recommendations on mirabegron (Betmiga) for treating overactive bladder in adults.
27 May 2022: This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. For people with COVID-19 see our guideline on managing COVID-19.
Supporting the health and care system to implement virtual wards
Virtual wards (also known as hospital at home) provide hospital level care at home.
Using NICE guidance in social work: scenarios for principal social workers
They can help principal social workers (PSWs) understand how to put our guidelines and quality standards into practice. Social care...
Find individual child abuse and neglect recommendations quickly and links to full guideline.
Resources, case studies and patient decision aids to show how you can use evidence to improve care and services
Antimicrobial prescribing: delafloxacin for community-acquired pneumonia (ES37)
Summary of the evidence on delafloxacin for community-acquired pneumonia in adults
Vitamin D: supplement use in specific population groups (PH56)
This guideline covers vitamin D supplement use. It aims to prevent vitamin D deficiency among specific population groups including infants and children aged under 4, pregnant and breastfeeding women, particularly teenagers and young women, people over 65, people who have low or no exposure to the sun and people with dark skin.